Morrisville-based Sicel Technologies, Inc. (www.siceltech.com), a medical device company making monitoring devices to aid oncologists, has completed a funding round that was three times the company's initial target. Burton Advisers of London led Sicel's “up-round” of funding, which also included other institutional investors, healthcare funds and private investors. Company officials said the funding would be used in the commercial launch of Sicel's first two products, both of which address the radiation oncology market.
Sicel's “flagship” product is an in vivo radiation sensor, designed to be implanted into a tumor in a patient to monitor radiation therapy. The device communicates radiation dose readings from the body to an external monitor via radio frequency coupling. Sicel's second product is a radiation dosimeter designed to stick on the skin of the patient like a “Band-Aid.”
Sicel Technologies is a CED member.